Effects of SGLT2 Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Heart Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐analysis of Randomized‐Controlled Trials
J Am Heart Assoc 2021 Feb 01;10(5)e019463, YH Teo, YN Teo, NL Syn, CS Kow, CSY Yoong, BYQ Tan, TC Yeo, CH Lee, W Lin, CH SiaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.